Tom Wiklund

6.3k total citations
96 papers, 4.7k citations indexed

About

Tom Wiklund is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Tom Wiklund has authored 96 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 40 papers in Pulmonary and Respiratory Medicine and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Tom Wiklund's work include Sarcoma Diagnosis and Treatment (30 papers), Vascular Tumors and Angiosarcomas (15 papers) and Lymphoma Diagnosis and Treatment (13 papers). Tom Wiklund is often cited by papers focused on Sarcoma Diagnosis and Treatment (30 papers), Vascular Tumors and Angiosarcomas (15 papers) and Lymphoma Diagnosis and Treatment (13 papers). Tom Wiklund collaborates with scholars based in Finland, Sweden and Norway. Tom Wiklund's co-authors include Carl Blomqvist, ­Eero Pukkala, Eric J. Holowaty, Michael Andersson, Hans H. Storm, Rochelle E. Curtis, Mary Gospodarowicz, Lois B. Travis, Inkeri Elomaa and Charles F. Lynch and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Tom Wiklund

92 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Wiklund Finland 32 1.9k 1.5k 1.3k 774 693 96 4.7k
Anna Kelsey United Kingdom 42 1.8k 1.0× 2.3k 1.5× 1.2k 0.9× 633 0.8× 2.6k 3.8× 151 5.7k
Felix Niggli Switzerland 44 1.7k 0.9× 1.8k 1.2× 1.3k 1.1× 485 0.6× 2.2k 3.1× 206 6.8k
Hélène Pacquement France 36 1.1k 0.6× 1.4k 0.9× 1.1k 0.9× 279 0.4× 748 1.1× 108 4.1k
Laura C. Bowman United States 42 2.3k 1.2× 972 0.6× 628 0.5× 473 0.6× 1.5k 2.2× 107 5.8k
J. S. Malpas United Kingdom 36 1.9k 1.0× 1.2k 0.8× 1.2k 0.9× 231 0.3× 1.4k 2.0× 109 5.5k
Roger R. Connelly United States 35 1.1k 0.6× 1.6k 1.0× 341 0.3× 607 0.8× 776 1.1× 73 3.8k
Jillian M. Birch United Kingdom 42 2.6k 1.4× 971 0.6× 1.0k 0.8× 996 1.3× 2.4k 3.5× 143 7.1k
J Lemerle France 42 1.3k 0.7× 1.2k 0.8× 869 0.7× 392 0.5× 1.8k 2.6× 158 5.4k
David Zahrieh United States 32 1.7k 0.9× 896 0.6× 875 0.7× 1.1k 1.4× 680 1.0× 71 4.3k
Beatrice C. Lampkin United States 38 1.2k 0.6× 1.1k 0.7× 653 0.5× 581 0.8× 2.4k 3.4× 107 5.4k

Countries citing papers authored by Tom Wiklund

Since Specialization
Citations

This map shows the geographic impact of Tom Wiklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Wiklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Wiklund more than expected).

Fields of papers citing papers by Tom Wiklund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Wiklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Wiklund. The network helps show where Tom Wiklund may publish in the future.

Co-authorship network of co-authors of Tom Wiklund

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Wiklund. A scholar is included among the top collaborators of Tom Wiklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Wiklund. Tom Wiklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Salminen, S, Tom Wiklund, Mika Sampo, et al.. (2019). Treatment and Prognosis of Radiation-Associated Breast Angiosarcoma in a Nationwide Population. Annals of Surgical Oncology. 27(4). 1002–1010. 22 indexed citations
3.
Papadopoulou, Anna, Amy B. Howell, & Tom Wiklund. (2015). Inhibition ofFlavobacterium psychrophilumadhesionin vitro. FEMS Microbiology Letters. 362(24). fnv203–fnv203. 8 indexed citations
4.
Persson, Jens, et al.. (2012). Förslag till samordning av inventering av järv i Sverige och Norge. BIBSYS Brage (BIBSYS (Norway)). 1 indexed citations
5.
Hernberg, Micaela, Aarne Kivioja, Tom Böhling, Rita Janes, & Tom Wiklund. (2010). Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma. Medical Oncology. 28(4). 1475–1480. 8 indexed citations
6.
Wiklund, Tom, et al.. (2010). Phase variation in Flavobacterium psychrophilum: characterization of two distinct colony phenotypes. Diseases of Aquatic Organisms. 90(1). 43–53. 19 indexed citations
7.
Wilking, Nils, Elisabet Lidbrink, Tom Wiklund, et al.. (2007). Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy. Annals of Oncology. 18(4). 694–700. 27 indexed citations
8.
Jantunen, Esa, Tom Wiklund, Eeva Juvonen, et al.. (2003). Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey. Bone Marrow Transplantation. 33(4). 405–410. 56 indexed citations
9.
Travis, Lois B., Deirdre A. Hill, Graça M. Dores, et al.. (2003). Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease. JAMA. 290(4). 465–465. 457 indexed citations
10.
Jantunen, Esa, Maija Itälä, Tuula Lehtinen, et al.. (2002). Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma. Leukemia & lymphoma. 43(6). 1229–1237. 13 indexed citations
11.
Bauer, Henrik C. F., Clement Trovik, Thor Alvegård, et al.. (2001). Monitoring referral and treatment in soft tissue sarcoma: Study based on 1,851 patients from the Scandinavian Sarcoma Group Register. Acta Orthopaedica Scandinavica. 72(2). 150–159. 97 indexed citations
12.
Bergh, Jonas, Tom Wiklund, Björn Erikstein, et al.. (2000). Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. The Lancet. 356(9239). 1384–1391. 217 indexed citations
13.
Travis, Lois B., Eric J. Holowaty, Kjell Bergfeldt, et al.. (1999). Risk of Leukemia after Platinum-Based Chemotherapy for Ovarian Cancer. New England Journal of Medicine. 340(5). 351–357. 256 indexed citations
14.
Bergh, Jonas, Tom Wiklund, Björn Erikstein, et al.. (1998). Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Annals of Oncology. 9(4). 403–411. 21 indexed citations
15.
Wiklund, Tom, Carl Blomqvist, Leila Risteli, et al.. (1996). Type I and type III collagen metabolites in adult osteosarcoma patients. British Journal of Cancer. 73(1). 106–109. 6 indexed citations
16.
Szymańska, Jadwiga A., Maija Tarkkanen, Tom Wiklund, et al.. (1995). A cytogenetic study of malignant fibrous histiocytoma. Cancer Genetics and Cytogenetics. 85(2). 91–96. 35 indexed citations
17.
Blomqvist, Carl, Tom Wiklund, Marjo Pajunen, Martti Virolainen, & Inkeri Elomaa. (1995). Oral trofosfamide: an active drug in the treatment of soft-tissue sarcoma. Cancer Chemotherapy and Pharmacology. 36(3). 263–265. 25 indexed citations
18.
Tarkkanen, Maija, Sakari Knuutila, Tom Wiklund, Martti Virolainen, & Inkeri Elomaa. (1994). Dedifferentiated chondrosarcoma with t(9;22)(q34;q 11‐12). Genes Chromosomes and Cancer. 9(2). 136–140. 21 indexed citations
19.
Wiklund, Tom, et al.. (1993). Impact of chemotherapy on collagen metabolism: a study of serum PIIINP (aminoterminal propeptide of type III procollagen) in advanced sarcomas. Journal of Cancer Research and Clinical Oncology. 119(3). 160–164. 4 indexed citations
20.
Wiklund, Tom, Thor Alvegård, Henning T. Mouridsen, Anders Rydholm, & Carl Blomqvist. (1993). Marginal surgery and postoperative radiotherapy in soft tissue sarcomas. European Journal of Cancer. 29(3). 306–309. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Kelsey Breakdown of academic impact, for papers by Felix Niggli Breakdown of academic impact, for papers by Hélène Pacquement Breakdown of academic impact, for papers by Laura C. Bowman Breakdown of academic impact, for papers by J. S. Malpas Breakdown of academic impact, for papers by Roger R. Connelly Breakdown of academic impact, for papers by Jillian M. Birch Breakdown of academic impact, for papers by J Lemerle Breakdown of academic impact, for papers by David Zahrieh Breakdown of academic impact, for papers by Beatrice C. Lampkin
Rankless by CCL
2026